Early research (Phase 1)WithdrawnNCT06681870
What this trial is testing
ASP1893 in Adults With Advanced CLDN6-positive Solid Tumors
Who this might be right for
CLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more
Astellas Pharma Global Development, Inc.